Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1997 6
1998 7
1999 7
2000 7
2001 5
2002 3
2003 7
2004 5
2005 3
2006 8
2007 6
2008 3
2009 6
2010 6
2011 6
2012 1
2013 3
2014 5
2015 3
2016 3
2017 6
2018 2
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 11704720

104 results

Results by year

Filters applied: . Clear all
Page 1
Interchangeability of vaccines.
Feldman S. Feldman S. Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S23-9. doi: 10.1097/00006454-200111001-00004. Pediatr Infect Dis J. 2001. PMID: 11704720 Review.
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Lagos R, et al. Pediatr Infect Dis J. 1998 Apr;17(4):294-304. doi: 10.1097/00006454-199804000-00006. Pediatr Infect Dis J. 1998. PMID: 9576383 Clinical Trial.
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, Moraga F, Boceta R, García-Martínez JA. Arístegui J, et al. Vaccine. 2003 Sep 8;21(25-26):3593-600. doi: 10.1016/s0264-410x(03)00420-1. Vaccine. 2003. PMID: 12922087 Clinical Trial.
Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T, Rivera L, Korhonen T, Ahonen A, Cheuvart B, Hezareh M, Janssens W, Mesaros N. Vesikari T, et al. Hum Vaccin Immunother. 2017 Jul 3;13(7):1505-1515. doi: 10.1080/21645515.2017.1294294. Epub 2017 Mar 24. Hum Vaccin Immunother. 2017. PMID: 28340322 Free PMC article. Clinical Trial.
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F, Knuf M, Heininger U, Jahn K, Collard A, Habermehl P, Schuerman L, Sänger R. Zepp F, et al. Vaccine. 2004 Jun 2;22(17-18):2226-33. doi: 10.1016/j.vaccine.2003.11.044. Vaccine. 2004. PMID: 15149781 Clinical Trial.
104 results